Literature DB >> 6167582

Complete primary structure of human C4a anaphylatoxin.

K E Moon, J P Gorski, T E Hugli.   

Abstract

C4a anaphylatoxin is derived from the fourth component (C4) of the blood complement system. The C4 alpha-chain is selectively cleaved between positions 77 and 78 by the protease C1s, a subcomponent of C1, generating the fragments C4a and C4b. Human C4a was isolated directly from fresh serum after C1 of the classical pathway of complement was activated by heat-aggregated gamma-globulin. The C4a anaphylatoxin is a cationic polypeptide of Mr = 9000 composed of 77 residues and devoid of histidine, tryptophan, and carbohydrate. The primary structure of human C4a was deduced from sequence analysis of two cyanogen bromide fragments and of peptides obtained after chymotryptic digestion of the COOH-terminal cyanogen bromide fragment. The proposed sequence is: (formula, see text) Manual alignment of the linear structures of human C3a, C4a, and C5a, based primarily on the location of two Cys-Cys sequences in each indicate a 30% homology between C3a and C4a and a 36% homology between C5a and C4a. It was concluded from the sequence comparison that C3a, C4a, and C5a are a family of bioactive factors derived from precursor molecules that share a common genetic origin. Although the human anaphylatoxins share a partial structural identity and express similar biological activities, these factors ae immunologically distinct molecules having no antigenic determinants in common as judged by radioimmunoassay.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6167582

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  C4a: An Anaphylatoxin in Name Only.

Authors:  Scott R Barnum
Journal:  J Innate Immun       Date:  2015-02-06       Impact factor: 7.349

2.  Common evolutionary origin of alpha 2-macroglobulin and complement components C3 and C4.

Authors:  L Sottrup-Jensen; T M Stepanik; T Kristensen; P B Lønblad; C M Jones; D M Wierzbicki; S Magnusson; H Domdey; R A Wetsel; A Lundwall
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

3.  Novel function of C4a anaphylatoxin. Release from monocytes of protein which inhibits monocyte chemotaxis.

Authors:  T Tsuruta; T Yamamoto; S Matsubara; S Nagasawa; S Tanase; J Tanaka; K Takagi; T Kambara
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

4.  Identification and partial characterization of the secreted form of the fourth component of human complement: evidence that it is different from major plasma form.

Authors:  A C Chan; K R Mitchell; T W Munns; D R Karp; J P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

Review 5.  Structure and function of the anaphylatoxins.

Authors:  T E Hugli
Journal:  Springer Semin Immunopathol       Date:  1984

6.  Amino acid sequence homologies and glycosylation differences between the fourth component of murine complement and sex-limited protein.

Authors:  D R Karp; K L Parker; D C Shreffler; C Slaughter; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

7.  Characterization of the Mr difference between secreted murine fourth component of complement and the major plasma form: evidence for carboxyl-terminal cleavage of the alpha chain.

Authors:  D R Karp; D C Shreffler; J P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

8.  A general method for affinity purification of complement component C3b using factor H-sepharose.

Authors:  J D Scott; J E Fothergill
Journal:  Biochem J       Date:  1982-09-01       Impact factor: 3.857

9.  The serine proteinase chain of human complement component C1s. Cyanogen bromide cleavage and N-terminal sequences of the fragments.

Authors:  P E Carter; B Dunbar; J E Fothergill
Journal:  Biochem J       Date:  1983-12-01       Impact factor: 3.857

10.  Primary structure of bovine complement activation fragment C4a, the third anaphylatoxin. Purification and complete amino acid sequence.

Authors:  M A Smith; L M Gerrie; B Dunbar; J E Fothergill
Journal:  Biochem J       Date:  1982-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.